Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-25-005781
Filing Date
2025-09-23
Accepted
2025-09-23 14:02:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11384
2 d11995035_ex99-a.htm EX-99 6505
3 d11995035_ex99-b.htm EX-99 821
  Complete submission text file 0000919574-25-005781.txt   20383
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Subject) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92951 | Film No.: 251332838
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1436 5TH STREET SUITE 3-210 MANHATTAN BEACH CA 90266
Business Address 1436 5TH STREET SUITE 3-210 MANHATTAN BEACH CA 90266 424-200-6630
GordonMD Global Investments LP (Filed by) CIK: 0002039349 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G